Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Forms Subsidiary in India

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen today said that it has established a subsidiary in New Delhi, India, to sell its products directly to the Indian market.

The firm had been using distributors for its products in the country, but it believes setting up the new subsidiary will further its growth in the emerging market.

Qiagen expects the New Delhi office will have more than 30 employees by the end of this year.

India's life sciences and biotech market provided industry-wide revenues of $5 billion in 2010, and it is expected to double by 2015, according to Qiagen. In addition, the firm said that India's in vitro diagnostics industry is projected to grow 15 percent annually over the next several years and "accelerate going forward due to government incentive programs and infrastructure investment."

"The great potential for our molecular diagnostic technologies to serve patients in India, along with the research needs of the country's robust pharmaceutical segment, emerging applied testing market, and a rapidly increasing academic market, makes India a perfect fit for our growth and geographic expansion goals," Qiagen CEO Peer Schatz said in a statement.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.